Screen, Initiate, Protect (SIP) Campaign
A campaign that encourages regular screening in CKD at risk patients and initiate guideline-directed therapy such as Empagliflozin to protect their kidneys early
Month 3 : Cardio-RENAL-Metabolic
Screen
Why is it important for PCPs to screen early for kidney disease among higher-risk patients such as HPN, T2D?
Initiate
Latest guideline in patients with T2D, CKD
Protect
Early initiation to delay 26.6 years of kidney replacement therapy
Take a SIP - Prof Green 2 - Importance of eGFR and UACR screening
Prof. Jennifer Green
Take a SIP - Prof Jarvis 1 - Tips for SIP when initiating SGLT2i in T2D
Prof. Sarah Jarvis
Month 2 : CKD at risk (T2D, HTN)
Month 1 : CKD
PCP’s role in DKD management & when to refer to endocrinologist
Prof. Jennifer Green
Document ID: PC-TH-104903